Rymedi 和 Precision Genetics 聯手實現精準醫學突破

Rymedi 和 Precision Genetics 的突破性合作旨在透過精準醫療徹底改變醫療保健。 Precision Genetics 的 PrecisionOp 解決方案可減輕手術中的藥物不良反應，而 Rymedi 的臨床試驗平台使 Precision Genetics 的 PROMISRx 註冊表能夠識別藥物反應的預測因子。該聯盟整合了 Web3、DeSci 和區塊鏈技術（在 Rymedi 的 Avalanche 子網上無縫管理），以提高患者治療效果，強調 Rymedi 對去中心化醫療保健解決方案的承諾，並重塑醫療保健範例。

Rymedi and Precision Genetics Forge Strategic Alliance to Advance Precision Medicine

Rymedi 與 Precision Genetics 結成策略聯盟，推進精準醫學

In a groundbreaking collaboration, Rymedi and Precision Genetics, two industry leaders in healthcare technology, have announced a strategic partnership that aims to revolutionize health outcomes and operational efficiency through the transformative power of precision medicine.

在一項開創性的合作中，醫療保健技術領域的兩家行業領導者 Rymedi 和 Precision Genetics 宣佈建立策略合作夥伴關係，旨在透過精準醫療的變革力量徹底改變健康結果和營運效率。

PrecisionOp: Personalized Solutions for Safer Surgeries

PrecisionOp：實現更安全手術的個人化解決方案

Precision Genetics contributes its flagship offering, PrecisionOp, to the partnership. PrecisionOp is a personalized solution that aims to mitigate adverse drug reactions and reduce reliance on post-operative opioids for surgical patients. By tailoring drug regimens based on genetic information, PrecisionOp minimizes risks and optimizes recovery after surgery, empowering clinicians with data-driven insights that can lead to better patient outcomes.

Precision Genetics 為此次合作貢獻了其旗艦產品 PrecisionOp。 PrecisionOp 是一種個人化解決方案，旨在減輕藥物不良反應並減少手術患者對術後鴉片類藥物的依賴。透過根據遺傳資訊客製化藥物治療方案，PrecisionOp 可最大限度地降低風險並優化術後恢復，為臨床醫生提供數據驅動的見解，從而改善患者的治療效果。

Rymedi's Blockchain-Enabled Clinical Trial Platform

Rymedi 的區塊鏈臨床試驗平台

Rymedi's clinical trial and registry platform plays a pivotal role in this partnership. It will support Precision Genetics' ambitious research study: Prospective Outcomes & Molecular Implementation Support Registry (PROMISRx). PROMISRx focuses on tracking, analyzing, and identifying predictors of medication response in surgical patients. Armed with genetic insights, clinicians can fine-tune treatment plans, enhancing patient outcomes and minimizing the risks associated with trial-and-error approaches.

Rymedi 的臨床試驗和註冊平台在此次合作中發揮關鍵作用。它將支持 Precision Genetics 雄心勃勃的研究：前瞻性結果和分子實施支持註冊中心 (PROMISRx)。 PROMISRx 專注於追蹤、分析和識別手術患者藥物反應的預測因子。憑藉遺傳見解，臨床醫生可以微調治療計劃，改善患者的治療效果並最大限度地降低與試誤方法相關的風險。

David Stefanich's Vision: Web3 and DeSci Solutions

David Stefanich 的願景：Web3 和 DeSci 解決方案

David Stefanich, CEO and Founder of Rymedi, emphasizes the global impact of this partnership. It signifies Rymedi's commitment to integrating Web3 and decentralized science (DeSci) solutions into clinical trial management, leveraging the power of blockchain technology to enhance healthcare efficiency and transparency. The marriage of blockchain technology and precision medicine holds immense promise for the healthcare industry, opening up new possibilities for data sharing, collaboration, and patient engagement.

Rymedi 執行長兼創辦人 David Stefanich 強調了此次合作的全球影響力。它標誌著 Rymedi 致力於將 Web3 和去中心化科學 (DeSci) 解決方案整合到臨床試驗管理中，利用區塊鏈技術的力量來提高醫療保健效率和透明度。區塊鏈技術和精準醫療的結合為醫療保健產業帶來了巨大的希望，為數據共享、協作和患者參與開闢了新的可能性。

Avalanche Subnets: Rymedi's Infrastructure Management

Avalanche 子網路：Rymedi 的基礎設施管理

Rymedi efficiently manages its operations across three distinct Avalanche subnets. From deployment to scaling, their internal development team oversees the entire infrastructure. Zeeve, a compliant BlaaS (Blockchain as a Service) platform, ensures enterprise-grade security, performance, and reliability, providing a robust foundation for the partnership's initiatives.

Rymedi 有效管理三個不同 Avalanche 子網路的運作。從部署到擴展，他們的內部開發團隊負責監督整個基礎架構。 Zeeve 是一個合規的 BlaaS（區塊鏈即服務）平台，可確保企業級安全性、效能和可靠性，為合作夥伴的計畫提供堅實的基礎。

A Paradigm Shift in Healthcare

醫療保健的典範轉移

In summary, Rymedi and Precision Genetics are poised to reshape healthcare paradigms. Their strategic partnership bridges cutting-edge technology with patient-centric care, ushering in an era of precision medicine for all. By harnessing the power of data, genetics, and blockchain, they aim to revolutionize treatment strategies, improve patient outcomes, and streamline clinical trial processes, ultimately delivering a future where healthcare is tailored to the unique needs of each individual.

總之，Rymedi 和 Precision Genetics 準備重塑醫療保健範式。他們的策略夥伴關係將尖端技術與以患者為中心的護理聯繫起來，開創了全民精準醫療的時代。透過利用數據、遺傳學和區塊鏈的力量，他們的目標是徹底改變治療策略、改善患者治療結果並簡化臨床試驗流程，最終實現一個根據每個人的獨特需求量身定制醫療保健的未來。